Home Cart 0 Sign in  
X

[ CAS No. 1117-71-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1117-71-1
Chemical Structure| 1117-71-1
Chemical Structure| 1117-71-1
Structure of 1117-71-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1117-71-1 ]

Related Doc. of [ 1117-71-1 ]

Alternatived Products of [ 1117-71-1 ]

Product Details of [ 1117-71-1 ]

CAS No. :1117-71-1 MDL No. :MFCD00000246
Formula : C5H7BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :RWIKCBHOVNDESJ-NSCUHMNNSA-N
M.W : 179.01 Pubchem ID :5369175
Synonyms :

Calculated chemistry of [ 1117-71-1 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.4
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 34.83
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.06
Log Po/w (XLOGP3) : 1.13
Log Po/w (WLOGP) : 1.11
Log Po/w (MLOGP) : 1.34
Log Po/w (SILICOS-IT) : 1.17
Consensus Log Po/w : 1.36

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.46
Solubility : 6.15 mg/ml ; 0.0344 mol/l
Class : Very soluble
Log S (Ali) : -1.28
Solubility : 9.48 mg/ml ; 0.053 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.3
Solubility : 8.93 mg/ml ; 0.0499 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.7

Safety of [ 1117-71-1 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P210-P264-P280-P370+P378-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P403+P235-P405-P403+P235-P405 UN#:1760
Hazard Statements:H314-H227 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1117-71-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1117-71-1 ]
  • Downstream synthetic route of [ 1117-71-1 ]

[ 1117-71-1 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 1117-71-1 ]
  • [ 13991-36-1 ]
YieldReaction ConditionsOperation in experiment
82% With lithium hydroxide monohydrate; water In tetrahydrofuran at 0℃; for 3 h; Inert atmosphere The (E) -4- bromo crotonate 6g (33.5mmol) was dissolved in THF (60ml) cooled to to 0 ,Under the protection of N2 was added dropwise lithium hydroxide monohydrate 1.83g (43.6mmol) in water(20mL). After the dropping 15min, 0 kept stirred 3h. And then cold water 150ml200ml of petroleum ether was added to the system to continue stirring 10min at 0 . Separating the aqueous phase, at 0 PH adjusted with concentrated hydrochloric acid to 1, with dichloromethane (80mlx3) and extracted. The combined organicPhase was dried over anhydrous sodium sulfate and concentrated to give compound X, a yellow solid 4.5g, 82percent yield.In the E-4- mixed with X-bromo crotonic acid and a drop of DMF in DCM (3ml) was added dropwise a solution of oxalylChlorine (0.025g, 1.96mmol). After the dropwise addition, stirring was raised to room temperature for 1h. Completion of the reaction,The solvent was concentrated to afford the intermediate (E) -4- bromo-2-enoyl chloride III, without further treatment,It was used directly in the next reaction.
82% With lithium hydroxide monohydrate In tetrahydrofuran; water at 0℃; for 3 h; Inert atmosphere A solution of methyl (E) -4-bromocrotonate (6 g, 33.5 mmol) in THF (60 mL) was cooled to 0 ° C, an aqueous solution (20 mL) of lithium hydroxide monohydrate (1.83 g, 43.6 mmol) was added dropwise under N2. After 15 min dripping, keep 0 ° C for 3 h. The cold water (150 mL) and petroleum ether (200 mL) were then added to the system and stirring was continued at 0 ° C for 10 min. The aqueous phase was separated, adjusted to pH 1 with concentrated hydrochloric acid at 0 ° C and extracted with dichloromethane (80 mL x 3). The organic phases were combined, dried over anhydrous sodium sulfate and concentrated to give E-4-bromocrotonic acid III as a yellow solid (4.5 g, yield 82percent).
64.3% With lithium hydroxide In tetrahydrofuran; water for 3 h; A mixture of (E) -4-bromo-2-butenoic acid methyl ester la (10 g, 0.056 mol)Was dissolved in 30 mL of tetrahydrofuran,To the reaction mixture, 30 mL of an aqueous solution of lithium hydroxide (3.05 g, 0.073 m) was slowly added dropwise,After the addition was complete, the reaction was stirred for 3 hours.The reaction solution was extracted with 50 mL of ethyl acetate,The aqueous phase was adjusted to pH <1 with 6M hydrochloric acid,Extraction with dichloromethane (100 mL X2)The organic phases were combined,The organic phase was concentrated under reduced pressure,(E) -4-bromo-2-butenoic acid lb (5.93 g, yellow oil)Yield: 64.3percent
40%
Stage #1: With lithium hydroxide monohydrate; water In tetrahydrofuran at 0℃; for 3.75 h; Inert atmosphere of nitrogen
Stage #2: With sulfuric acid In water
To a stirred homogeneous solution of (E)-methyl 4-bromobut-2-enoate (53.7 g, 300 mmol) in THF (100 mL) at 0 °C (bath temperature) under a nitrogen atmosphere, was added a solution of lithium hydroxide monohydrate (16.4 g, 390 mmol) in water (80 mL) dropwise (over 35 min). After addition the mixture was stirred at 0 "C for 3 h. Cold water (300 mL) and petroleum ether (400 mL) were added and the mixture was stirred at 0 °C for 10 min. The organic layer was separated and discarded. Ethyl acetate/petroleum ether (1:10, 300 mL) was then added and-the mixture was again stirred at 0 °C for 10 min before the organic layer was separated and discarded. The aqueous solution was acidified with cone, sulfuric acid at 0 °C to pH <; 1. The product was extracted into dichloromediane (400 mL; 200 mL) and the combined organic extracts were dried (MgSO4) and evaporated under reduced pressure at 35 °C (bath temperature) to give a yellow oil. The oil was stirred with petroleum ether (2x500 mL) at 50 °C (bath temperature). The combined petroleum ether extracts were concentrated under reduced pressure at 20-25 °C (bath) to induce precipitation of the product The suspension was then stood at 5 UC overnight before the solid was collected by filtration, washed with cold petroleum ether and dried to give (E)-4-bromobut-2-enoic acid (9) (19.9g, 40percent).

Reference: [1] Patent: CN105669521, 2016, A, . Location in patent: Paragraph 0104; 0105; 0106
[2] Patent: CN106946896, 2017, A, . Location in patent: Paragraph 0054
[3] Tetrahedron Letters, 1991, vol. 32, # 34, p. 4239 - 4242
[4] Tetrahedron, 1993, vol. 49, # 18, p. 3691 - 3734
[5] Journal of Organic Chemistry, 1994, vol. 59, # 24, p. 7259 - 7266
[6] Tetrahedron Letters, 1991, vol. 32, # 34, p. 4239 - 4242
[7] Patent: CN103987700, 2016, B, . Location in patent: Paragraph 0164-0166
[8] Patent: WO2010/104406, 2010, A1, . Location in patent: Page/Page column 77
[9] Journal of the Chemical Society, 1949, p. 3104
[10] Justus Liebigs Annalen der Chemie, 1942, vol. 551, p. 115
[11] Journal of Medicinal Chemistry, 2001, vol. 44, # 17, p. 2719 - 2734
[12] Patent: EP1950201, 2008, A1, . Location in patent: Page/Page column 58
[13] Patent: EP1117659, 2003, B1, . Location in patent: Page 54
[14] Patent: EP1171440, 2004, B1, . Location in patent: Page 45
[15] Patent: US2005/250761, 2005, A1, . Location in patent: Page/Page column 13-14
  • 2
  • [ 1117-71-1 ]
  • [ 10035-10-6 ]
  • [ 13991-36-1 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1942, vol. 551, p. 115
  • 3
  • [ 67-56-1 ]
  • [ 13991-36-1 ]
  • [ 1117-71-1 ]
YieldReaction ConditionsOperation in experiment
93.1% at 0℃; for 15 h; Compound 25 (1.525 g, 9.24 mmol) and anhydrous methanol (10 ml) were added to a 50 ml three-necked flask, stirred at 0° C. until dissolved, and SoCl2 (5.49 g, 46.19 mmol, 5 ml) was slowly added dropwise to generate bubbles. After completion, the temperature was raised to room temperature, stirring was continued for 15 hours, and the reaction was completed by TLC. The solvent was evaporated to dryness, and the mixture was extracted with ethyl acetate/water. The product was in the organic phase, and the liquid was separated. The organic phase was collected and dried over Na 2 SO 4 . The solvent was removed by spin-drying to give a crude product, which was purified by column chromatography. Petroleum ether: ethyl acetate = 8 The elution of: 1 gave a red oily liquid of compound 26, 1.54 g, yield: 93.1percent.
Reference: [1] Patent: CN107556289, 2018, A, . Location in patent: Paragraph 0112; 0117; 0118; 0119
[2] Tetrahedron Asymmetry, 2009, vol. 20, # 10, p. 1164 - 1167
  • 4
  • [ 623-43-8 ]
  • [ 1117-71-1 ]
YieldReaction ConditionsOperation in experiment
34 g With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 6 h; Reflux The compound crotonic acid methyl ester (20 g, 200 mmol) was added to a 500 ml single-necked flask,Treated with carbon tetrachloride (200 ml)A mixture of azobisisobutyronitrile (AIBN) (66 mg, 0.4 mmol)And N-bromosuccinimide (NBS) (39.1 g, 220 mmol)The reaction solution was allowed to react for 6 hours under reflux,cool down,The solid was removed by filtration,The filtrate was washed with water (20 ml x 3), dried over anhydrous Na2SO4,Filtration by spinning gave a yellow oil 4-bromocrotonic acid methyl ester (34 g)The compound was used directly in the next step without purification.
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 11, p. 1629 - 1632
[2] Tetrahedron, 1988, vol. 44, # 9, p. 2541 - 2548
[3] Phytochemistry (Elsevier), 1983, vol. 22, # 4, p. 1028 - 1030
[4] Angewandte Chemie - International Edition, 2007, vol. 46, # 7, p. 1066 - 1070
[5] Journal of the Indian Chemical Society, 2002, vol. 79, # 11, p. 876 - 883
[6] Australian Journal of Chemistry, 1978, vol. 31, p. 863 - 891
[7] Tetrahedron Letters, 1989, vol. 30, # 52, p. 7399 - 7402
[8] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 12, p. 2921 - 2926
[9] Revue Roumaine de Chimie, 2002, vol. 47, # 6, p. 543 - 544
[10] Patent: US4886817, 1989, A,
[11] Patent: CN106146511, 2016, A, . Location in patent: Paragraph 0249; 0250; 0251
  • 5
  • [ 623-43-8 ]
  • [ 1117-71-1 ]
Reference: [1] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5243 - 5252
[2] Justus Liebigs Annalen der Chemie, 1942, vol. 551, p. 115
[3] Chemische Berichte, 1948, vol. 81, p. 368,371
[4] Justus Liebigs Annalen der Chemie, 1942, vol. 551, p. 115
[5] Chemische Berichte, 1948, vol. 81, p. 368,371
[6] Journal of the Chemical Society, 1949, p. 3104
[7] Helvetica Chimica Acta, 1946, vol. 29, p. 573,580
  • 6
  • [ 3724-65-0 ]
  • [ 1117-71-1 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 21, p. 5492 - 5495
  • 7
  • [ 623-43-8 ]
  • [ 1117-71-1 ]
  • [ 56699-18-4 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 5, p. 1438 - 1441
  • 8
  • [ 5837-73-0 ]
  • [ 1117-71-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1932, vol. 195, p. 389[2] Bulletin de la Societe Chimique de France, 1934, vol. &lt;5&gt;1, p. 1342
  • 9
  • [ 56-23-5 ]
  • [ 623-43-8 ]
  • [ 1117-71-1 ]
Reference: [1] Patent: US2790757, 1954, ,
  • 10
  • [ 56-23-5 ]
  • [ 3699-18-1 ]
  • [ 623-43-8 ]
  • [ 1117-71-1 ]
Reference: [1] Canadian Journal of Chemistry, 1955, vol. 33, p. 1724,1726[2] Org.Synth.Coll.Vol., 1963, vol. IV, p. 496
  • 11
  • [ 99848-36-9 ]
  • [ 71-43-2 ]
  • [ 1117-71-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1935, vol. 200, p. 2089[2] Bulletin de la Societe Chimique de France, 1938, vol. &lt;5&gt; 5, p. 1552,1560
  • 12
  • [ 67-56-1 ]
  • [ 60-29-7 ]
  • [ 99848-36-9 ]
  • [ 124-41-4 ]
  • [ 1117-71-1 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1935, vol. 200, p. 2089[2] Bulletin de la Societe Chimique de France, 1938, vol. &lt;5&gt; 5, p. 1552,1560
  • 13
  • [ 60-29-7 ]
  • [ 5837-73-0 ]
  • [ 7789-60-8 ]
  • [ 1117-71-1 ]
  • [ 137207-24-0 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1932, vol. 195, p. 389[2] Bulletin de la Societe Chimique de France, 1934, vol. &lt;5&gt;1, p. 1342
  • 14
  • [ 1117-71-1 ]
  • [ 5164-76-1 ]
  • [ 4756-84-7 ]
Reference: [1] Tetrahedron, 1992, vol. 48, # 15, p. 3147 - 3162
  • 15
  • [ 67-56-1 ]
  • [ 1117-71-1 ]
  • [ 5164-76-1 ]
  • [ 4756-84-7 ]
Reference: [1] Tetrahedron, 1992, vol. 48, # 15, p. 3147 - 3162
  • 16
  • [ 1117-71-1 ]
  • [ 17151-48-3 ]
  • [ 4619-18-5 ]
Reference: [1] Synthetic Communications, 1991, vol. 21, # 8-9, p. 981 - 987
  • 17
  • [ 1117-71-1 ]
  • [ 17151-47-2 ]
  • [ 589-06-0 ]
Reference: [1] Synthetic Communications, 1991, vol. 21, # 8-9, p. 981 - 987
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1117-71-1 ]

Alkenes

Chemical Structure| 37746-78-4

[ 37746-78-4 ]

(E)-Ethyl 4-bromobut-2-enoate

Similarity: 0.93

Chemical Structure| 2756-87-8

[ 2756-87-8 ]

(E)-4-methoxy-4-oxobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 13991-36-1

[ 13991-36-1 ]

(E)-4-Bromobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 2459-05-4

[ 2459-05-4 ]

(E)-4-Ethoxy-4-oxobut-2-enoic acid

Similarity: 0.76

Chemical Structure| 924-50-5

[ 924-50-5 ]

Methyl-3,3-dimethylacrylate

Similarity: 0.73

Aliphatic Chain Hydrocarbons

Chemical Structure| 37746-78-4

[ 37746-78-4 ]

(E)-Ethyl 4-bromobut-2-enoate

Similarity: 0.93

Chemical Structure| 2756-87-8

[ 2756-87-8 ]

(E)-4-methoxy-4-oxobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 13991-36-1

[ 13991-36-1 ]

(E)-4-Bromobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 2459-05-4

[ 2459-05-4 ]

(E)-4-Ethoxy-4-oxobut-2-enoic acid

Similarity: 0.76

Chemical Structure| 924-50-5

[ 924-50-5 ]

Methyl-3,3-dimethylacrylate

Similarity: 0.73

Bromides

Chemical Structure| 37746-78-4

[ 37746-78-4 ]

(E)-Ethyl 4-bromobut-2-enoate

Similarity: 0.93

Chemical Structure| 13991-36-1

[ 13991-36-1 ]

(E)-4-Bromobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 61934-55-2

[ 61934-55-2 ]

4-(Bromomethyl)furan-2(5H)-one

Similarity: 0.73

Chemical Structure| 946-99-6

[ 946-99-6 ]

Methyl 3-(4-(bromomethyl)phenyl)acrylate

Similarity: 0.68

Chemical Structure| 3650-78-0

[ 3650-78-0 ]

Methyl 3-(4-bromophenyl)acrylate

Similarity: 0.63

Esters

Chemical Structure| 37746-78-4

[ 37746-78-4 ]

(E)-Ethyl 4-bromobut-2-enoate

Similarity: 0.93

Chemical Structure| 2756-87-8

[ 2756-87-8 ]

(E)-4-methoxy-4-oxobut-2-enoic acid

Similarity: 0.81

Chemical Structure| 2459-05-4

[ 2459-05-4 ]

(E)-4-Ethoxy-4-oxobut-2-enoic acid

Similarity: 0.76

Chemical Structure| 497-23-4

[ 497-23-4 ]

Furan-2(5H)-one

Similarity: 0.73

Chemical Structure| 924-50-5

[ 924-50-5 ]

Methyl-3,3-dimethylacrylate

Similarity: 0.73